InsiderTrades

Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.

Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001415889-23-003083 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-23 2023-02-21 CAPR Litvack Frank Dir F - Tax $4.31 -4,524 137.3K -3% -$19.5K
D 2023-02-23 2023-02-21 CAPR Litvack Frank Dir M - OptEx $1.39 +14.0K 141.8K +11% +$19.5K
D 2023-02-23 2023-02-21 CAPR Litvack Frank Dir M - OptEx $0.00 -14.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-21 F D 4,524 $4.31 137,276 D — — (F1) Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on February 21, 2023 of $4.31. The options would otherwise expire on February 22, 2023, pursuant to their terms.
2 Common Common Stock 2023-02-21 M A 14,027 $1.39 141,800 D — —
3 Derivative Stock Option (Right to Buy) 2023-02-21 M D 14,027 $0.00 0 D $1.39 · — to 2023-02-22 14,027 Common Stock (F2) This option was granted on February 22, 2013 and was previously reported as covering 140,270 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F3) 25% of the shares vested immediately, with the remainder vesting monthly over 25 months commencing May 1, 2013.